Status | Study |
RECRUITING |
Study Name: MENDD Tolerance Assessment Study Condition: Short Bowel Syndrome Date: 2023-12-14 Interventions: A balloon device that will be introduced into participants' intestine over a guide wire to test the radial stretch of the small bowel. |
RECRUITING |
Study Name: A Feasibility Study to Evaluate Safety & Benefit of Eclipse XL1 System in Adult Patients With SBS Condition: Short Bowel Syndrome Date: 2022-09-01 Interventions: The surgeon verifies the intestinal diameter and selects the appropriate device diameter size.The device is introduced into the lumen of the int |
Recruiting |
Study Name: Use of Pancreatic Enzymes in Short Bowel Syndrome Condition: Short Bowel Syndrome Date: 2017-03-24 Interventions: Drug: Pancreatic Enzyme All subjects will take pancreatic enzymes at a dose appropriate for their weight |
Not yet recruiting |
Study Name: Amino Acid-based Oral Rehydration Solution in Children With Short Bowel Syndrome Condition: Short Bowel Syndrome Date: 2017-03-24 Interventions: Dietary Supplement: Enterade® oral rehydration solution Commercially available amino acid based ora |
Active, not recruiting |
Study Name: Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition Condition: Short Bowel Syndrome Date: 2016-01-27 Interventions: Drug: Teduglutide 0.05mg/kg 0. |
Recruiting |
Study Name: The Use of DPP-4 Inhibitors in Short Bowel Syndrome Condition: Short Bowel Syndrome Date: 2016-01-10 Interventions: Drug: Dipeptidyl peptidase-4 inhibitor Other Name: Sitagliptin |
Completed |
Study Name: Energy Metabolism in Patients With Short Bowel Syndrome Condition: Short Bowel Syndrome Date: 2014-04-10 |
Completed |
Study Name: Short Bowel Syndrome and Teduglutide Versus Placebo Condition: Short Bowel Syndrome Date: 2014-03-25 Interventions: Drug: Teduglutide Participants |
Recruiting |
Study Name: A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome Condition: Short Bowel Syndrome Date: 2013-11-11 |
Completed |
Study Name: A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Condition: Short Bowel Syndrome Date: 2013-09-23 Interventions: Drug: teduglutide Open label intervention. Each subject will be assigned to receive 0.0125, 0.025, or 0. |